Belinda A. Mohr currently serves as lead Health Economist on the Global Health Economics Team at W. L. Gore & Associates, Inc. She is committed to quantifying the value of Gore medical devices to multiple stakeholders by collaborating with internal associates and external researchers to leverage data on outcomes and costs. Prior to joining Gore, Dr. Mohr was an Economist for the U.S. Food and Drug Administration working on economic impact analyses of proposed regulations. She holds a Ph.D. in Economics from the University of California, Santa Barbara.